Ultragenyx Executive and Leadership Team

November, 2026

Leadership Overview

Ultragenyx has 4 executives leading key functions including financial strategy, portfolio management, human resources, and clinical development.

Focused on rare genetic disease therapeutics, Ultragenyx advances innovative biologics and small-molecule treatments to address significant unmet medical needs across global markets.

Leadership Roles at Ultragenyx

  • Chief Financial Officer & Executive VP, Corporate Strategy - Howard Horn
  • Chief of Staff and Head Senior Vice President, Program and Portfolio Management - Alyssa Moore
  • Executive Vice President & Chief Human Resources Officer - Ernie Meyer
  • Chief Medical Officer & Executive Vice President - Eric Crombez
  • Howard Horn - Chief Financial Officer & Executive VP, Corporate Strategy

    Howard Horn, the Chief Financial Officer & Executive VP, Corporate Strategy at Ultragenyx, directs all fiscal operations and long-term capital allocation. Managing the financial health of the organization, the Chief Financial Officer & Executive VP, Corporate Strategy oversees investor relations and corporate planning to support the development of rare disease therapeutics. This leadership role involves balancing complex R&D investments with sustainable growth objectives across North American and European markets. By optimizing the capital structure, Howard Horn directly impacts the ability of the company to fund clinical programs for metabolic and bone disorders. Furthermore, the Chief Financial Officer & Executive VP, Corporate Strategy collaborates with the Board to refine strategic priorities, ensuring that financial resources align with the mission of delivering life-changing treatments to patients with limited options.
    Howard Horn

    Alyssa Moore - Chief of Staff and Head Senior Vice President, Program and Portfolio Management

    Alyssa Moore, the Chief of Staff and Head Senior Vice President, Program and Portfolio Management at Ultragenyx, coordinates cross-functional execution across the entire drug development pipeline. Overseeing the integration of clinical programs, the Chief of Staff and Head Senior Vice President, Program and Portfolio Management ensures that research milestones meet rigorous internal standards. This role involves managing the lifecycle of biologics and small-molecule therapeutics, facilitating communication between scientific teams and executive leadership. By streamlining operational workflows, Alyssa Moore drives efficiency in the advancement of treatments for rare genetic conditions. The Chief of Staff and Head Senior Vice President, Program and Portfolio Management also monitors global portfolio health, identifying potential bottlenecks in clinical trials to maintain momentum in the competitive biopharmaceutical landscape while supporting the overarching corporate strategy.

    Ernie Meyer - Executive Vice President & Chief Human Resources Officer

    Ernie Meyer, the Executive Vice President & Chief Human Resources Officer at Ultragenyx, directs talent acquisition and organizational development initiatives. Cultivating a high-performance culture, the Executive Vice President & Chief Human Resources Officer manages global workforce planning to support the expansion of clinical research capabilities. This leadership role involves designing compensation structures and professional development programs that attract top-tier scientific talent to the biopharmaceutical sector. By fostering an environment of innovation, Ernie Meyer ensures that the company retains the expertise necessary to tackle complex genetic disorders. The Executive Vice President & Chief Human Resources Officer also aligns human capital strategies with the broader mission of addressing unmet medical needs, ensuring that internal teams remain agile and focused on the successful delivery of therapeutic solutions across international operations.

    Eric Crombez - Chief Medical Officer & Executive Vice President

    Eric Crombez, the Chief Medical Officer & Executive Vice President at Ultragenyx, directs all clinical development and medical affairs activities. Overseeing the design and execution of global clinical trials, the Chief Medical Officer & Executive Vice President ensures that therapeutic candidates for rare genetic diseases meet safety and efficacy benchmarks. This role involves collaborating with regulatory agencies and research institutions to advance the pipeline of metabolic and enzyme deficiency treatments. By providing medical oversight, Eric Crombez directly impacts the success of clinical programs in North America, Europe, and Asia. The Chief Medical Officer & Executive Vice President also guides the scientific strategy, ensuring that patient-centric data informs every stage of drug development, ultimately accelerating the path toward providing effective therapies for patients suffering from ultra-rare genetic conditions.

    Frequently Asked Questions Regarding Ultragenyx Top Executives and Leadership Team

    Who leads Ultragenyx?
    Ultragenyx is led by Howard Horn (Chief Financial Officer & Executive VP, Corporate Strategy), along with executives such as Alyssa Moore (Chief of Staff and Head Senior Vice President, Program and Portfolio Management) and Ernie Meyer (Executive Vice President & Chief Human Resources Officer).
    Who is part of Ultragenyx’s executive team?
    The executive team of Ultragenyx includes leaders such as Howard Horn (Chief Financial Officer & Executive VP, Corporate Strategy), Alyssa Moore (Chief of Staff and Head Senior Vice President, Program and Portfolio Management), Ernie Meyer (Executive Vice President & Chief Human Resources Officer) and other senior executives.
    How many executives does Ultragenyx have?
    Ultragenyx has 4 executives leading key business areas.
    What roles are included in Ultragenyx’s leadership team?
    The leadership team of Ultragenyx includes roles such as Chief Financial Officer & Executive VP, Corporate Strategy, Chief of Staff and Head Senior Vice President, Program and Portfolio Management, Executive Vice President & Chief Human Resources Officer, Chief Medical Officer & Executive Vice President.